Go Pro

Tvardi Therapeutics (TVRD) Institutional Ownership

Tvardi Therapeutics logo
$1.81 -0.05 (-2.69%)
As of 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Tvardi Therapeutics (NASDAQ:TVRD)

Current
Institutional Ownership
Percentage
44.66%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$18.20M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$54.36K
Get TVRD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tvardi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TVRD Institutional Buying and Selling by Quarter

Tvardi Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/20/2026 Susquehanna International Group LLP33,165$63K0.0%N/A0.354%
8/7/2026 BlackRock Inc.95,478$181K0.0%N/A1.018%
8/6/2026 GSA Capital Partners LLP17,885$34K0.0%N/A0.191%
5/14/2026 Renaissance Technologies LLC92,100$293K0.0%-11.9%0.982%
2/18/2026 XTX Topco Ltd12,838$55K0.0%N/A0.137%
2/18/2026 Quadrature Capital Ltd20,964$90K0.0%N/A0.223%
2/17/2026 Russell Investments Group Ltd.15,966$69K0.0%+1,351.5%0.170%
2/16/2026 Squarepoint Ops LLC51,783$223K0.0%+534.3%0.552%
2/16/2026 Arax Advisory Partners8,400$36K0.0%+277.2%0.090%
2/13/2026 Charles Schwab Investment Management Inc.11,802$51K0.0%-22.7%0.126%
2/13/2026 State Street Corp115,501$497K0.0%+83.7%1.231%
2/12/2026 Jane Street Group LLC47,444$204K0.0%N/A0.506%
2/12/2026 HRT Financial LP11,050$47K0.0%N/A0.118%
2/12/2026 Renaissance Technologies LLC104,500$449K0.0%+246.3%1.114%
2/12/2026 American Financial Group Inc.223,659$962K0.3%N/A2.384%
2/10/2026 Goldman Sachs Group Inc.33,131$142K0.0%+37.9%0.353%
2/9/2026 Geode Capital Management LLC157,133$676K0.0%+6.2%1.675%
2/5/2026 Duncan Williams Asset Management LLC80,771$347K0.1%+266.6%0.861%
11/17/2025 Vestal Point Capital LP167,000$6.51M0.3%N/A1.781%
11/17/2025 Parkman Healthcare Partners LLC65,000$2.53M0.3%N/A0.693%
11/14/2025 Schonfeld Strategic Advisors LLC19,132$746K0.0%N/A0.204%
11/14/2025 Squarepoint Ops LLC8,164$318K0.0%N/A0.087%
11/13/2025 Invesco Ltd.82,614$3.22M0.0%N/A0.881%
11/13/2025 UBS Group AG48,479$1.89M0.0%+65.2%0.517%
11/10/2025 Monaco Asset Management SAM13,590$530K0.0%N/A0.145%
11/7/2025Vanguard Group Inc.419,167$16.34M0.0%+5.2%4.470%
8/16/2025 Headlands Technologies LLC3,431$80K0.0%N/A0.037%
8/15/2025 Bank of America Corp DE17,085$399K0.0%N/A0.183%
8/15/2025 683 Capital Management LLC176,030$4.11M0.3%N/A1.881%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.1,863$43K0.0%N/A0.020%
8/14/2025 Slate Path Capital LP704,118$16.43M0.3%N/A7.523%
8/13/2025 Marshall Wace LLP24,980$583K0.0%N/A0.267%
8/13/2025 New York State Common Retirement Fund4,000$92K0.0%N/A0.043%
8/12/2025 JPMorgan Chase & Co.1,668$39K0.0%N/A0.018%
8/8/2025 Geode Capital Management LLC112,138$2.62M0.0%N/A1.198%


TVRD Institutional Ownership - Frequently Asked Questions

During the previous two years, 32 institutional investors and hedge funds held shares of Tvardi Therapeutics. The most heavily invested institutionals were Slate Path Capital LP ($16.43M), Vanguard Group Inc. ($16.34M), Vestal Point Capital LP ($6.51M), 683 Capital Management LLC ($4.11M), Invesco Ltd. ($3.22M), Parkman Healthcare Partners LLC ($2.53M), and UBS Group AG ($1.89M).Learn more on Tvardi Therapeutics' institutional investors.

44.66% of Tvardi Therapeutics' stock is owned by institutional investors. Learn more on TVRD's institutional investor holdings.

Of the 31 institutional investors that purchased Tvardi Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Slate Path Capital LP ($704.12K), American Financial Group Inc. ($223.66K), 683 Capital Management LLC ($176.03K), Vestal Point Capital LP ($167K), Geode Capital Management LLC ($121.35K), BlackRock Inc. ($95.48K), and Invesco Ltd. ($82.61K).

Institutional investors have bought a total of 1,126,543 shares in the last 24 months. This purchase volume represents approximately $18.20M in transactions.

The following institutional investors have sold Tvardi Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($12.40K), and Charles Schwab Investment Management Inc. ($3.47K).

Institutional investors have sold a total of 15,872 shares in the last 24 months. This volume of shares sold represents approximately $54.36K in transactions.



Institutional ownership data for NASDAQ:TVRD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/20/2026. New 13F filings are added each quarter as they're published.
From Our Partners